Harvard Bioscience

Life Sciences Tools & Services
Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

$37.1M

Market Cap • 9/10/2026

2000

(26 years)

Founded

2000

(26 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5

P/S

0,4

P/EBITDA

7,2

P/OCF

57

P/FCF

P/E

BVPS

1,7

EPS

Market Cap

Market Cap

37,1M

EV

73,2M

EV/Revenue

0,8

EV/EBITDA

14,2

EV/EBIT

-298,8

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Payout

0%

Retained Earnings

-221M

Profitability

Gross Margin

58,2%

EBITDA Margin

5,9%

EBIT Margin

Net Margin

D&A/EBITDA

64,9%

R&D/Revenue

10,4%

Capex/Revenue

2%

Capex/D&A

32,8%

Capex/OCF

271,9%

SBC/OCF

218,1%

% PPE

15,4%

% Goodwill

12,2%

ROE

ROIC

Growth

CAGR Revenue 5Y

-4,6%

CAGR Net Income 5Y

30,1%

CAGR EPS 5Y

23,6%

CAGR OCF 5Y

-35,6%

Leverage

N.D./EBITDA

7

Debt/Equity

0%

Current Ratio

1,9

Quick Ratio

0,8

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium